Induction of type I and type III interferons by Borrelia burgdorferi correlates with pathogenesis and requires linear plasmid 36

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Krupna Gaylord, Michelle A ^a,b   Liveris, Dionysios ^a   Love, Andrea C ^a   Wormser, Gary P ^a   Schwartz, Ira ^a   Petzke, Mary M ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 29; INTERLEUKIN 3; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA; AUTACOID; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON; MESSENGER RNA;

ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BORRELIA BURGDORFERI; CELL FUNCTION; CONTROLLED STUDY; DENDRITIC CELL; ENZYME INDUCTION; GENOTYPE; HUMAN; HUMAN CELL; LINEAR PLASMID 36; LYME DISEASE; NONHUMAN; PATHOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PHAGOCYTOSIS; PLASMID; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; ADULT; BACTERIUM ADHERENCE; GENETICS; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGY; MONONUCLEAR CELL; MUTATION; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ADULT; BACTERIAL ADHESION; BORRELIA BURGDORFERI; CYTOKINES; DENDRITIC CELLS; GENOTYPE; HUMANS; INFLAMMATION MEDIATORS; INTERFERONS; LEUKOCYTES, MONONUCLEAR; LYME DISEASE; MUTATION; NF-KAPPA B; PHAGOCYTOSIS; PLASMIDS; RNA, MESSENGER; SIGNAL TRANSDUCTION;

EID: 84903386056     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0100174     Document Type: Article

References (101)

1. Steere AC (1989) Lyme disease. N Engl J Med 321: 586-596.
2. Steere AC (2001) Lyme disease. N Engl J Med 345: 115-125.
3. Steere AC, Bartenhagen NH, Craft JE, Hutchinson GJ, Newman JH, et al. (1986) Clinical manifestations of Lyme disease. Zentralbl Bakteriol Mikrobiol Hyg A 263: 201-205.
4. Fraser CM, Casjens S, Huang WM, Sutton GG, Clayton R, et al. (1997) Genomic sequence of a Lyme disease spirochaete, Borrelia burgdorferi. Nature 390: 580-586. (Pubitemid 28016185)
5. Casjens S, Palmer N, van Vugt R, Huang WM, Stevenson B, et al. (2000) A bacterial genome in flux: the twelve linear and nine circular extrachromosomal DNAs in an infectious isolate of the Lyme disease spirochete Borrelia burgdorferi. Mol Microbiol 35: 490-516. (Pubitemid 30085269)
6. Palmer N, Fraser C, Casjens S (2000) Distribution of twelve linear extrachromosomal DNAs in natural isolates of Lyme disease spirochetes. J Bacteriol 182: 2476-2480. (Pubitemid 30212905)
7. Terekhova D, Iyer R, Wormser GP, Schwartz I (2006) Comparative genome hybridization reveals substantial variation among clinical isolates of Borrelia burgdorferi sensu stricto with different pathogenic properties. J Bacteriol 188: 6124-6134. (Pubitemid 44448554)
8. Liveris D, Gazumyan A, Schwartz I (1995) Molecular typing of Borrelia burgdorferi sensu lato by PCR-restriction fragment length polymorphism analysis. J Clin Microbiol 33: 589-595.
9. Liveris D, Wormser GP, Nowakowski J, Nadelman R, Bittker S, et al. (1996) Molecular typing of Borrelia burgdorferi from Lyme disease patients by PCR-restriction fragment length polymorphism analysis. J Clin Microbiol 34: 1306-1309. (Pubitemid 26126916)
10. Wang G, Ojaimi C, Iyer R, Saksenberg V, McClain SA, et al. (2001) Impact of genotypic variation of Borrelia burgdorferi sensu stricto on kinetics of dissemination and severity of disease in C3H/HeJ mice. Infect Immun 69: 4303-4312. (Pubitemid 32574426)
11. Wang G, Ojaimi C, Wu H, Saksenberg V, Iyer R, et al. (2002) Disease severity in a murine model of lyme borreliosis is associated with the genotype of the infecting Borrelia burgdorferi sensu stricto strain. J Infect Dis 186: 782-791. (Pubitemid 35013430)
12. Wormser GP, Brisson D, Liveris D, Hanincova K, Sandigursky S, et al. (2008) Borrelia burgdorferi genotype predicts the capacity for hematogenous dissemination during early Lyme disease. J Infect Dis 198: 1358-1364.
13. Wormser GP, Liveris D, Nowakowski J, Nadelman RB, Cavaliere LF, et al. (1999) Association of specific subtypes of Borrelia burgdorferi with hematogenous dissemination in early Lyme disease. J Infect Dis 180: 720-725. (Pubitemid 29411358)
14. Wooten RM, Ma Y, Yoder RA, Brown JP, Weis JH, et al. (2002) Toll-like receptor 2 plays a pivotal role in host defense and inflammatory response to Borrelia burgdorferi. Vector Borne Zoonotic Dis 2: 275-278.
15. Akira S (2003) Mammalian Toll-like receptors. Curr Opin Immunol 15: 5-11.
16. Moore MW, Cruz AR, LaVake CJ, Marzo AL, Eggers CH, et al. (2007) Phagocytosis of Borrelia burgdorferi and Treponema pallidum potentiates innate immune activation and induces gamma interferon production. Infect Immun 75: 2046-2062. (Pubitemid 46559474)
17. Cruz AR, Moore MW, La Vake CJ, Eggers CH, Salazar JC, et al. (2008) Phagocytosis of Borrelia burgdorferi, the Lyme disease spirochete, potentiates innate immune activation and induces apoptosis in human monocytes. Infect Immun 76: 56-70.
18. Sjowall J, Fryland L, Nordberg M, Sjogren F, Garpmo U, et al. (2011) Decreased Th1-type inflammatory cytokine expression in the skin is associated with persisting symptoms after treatment of erythema migrans. PLoS One 6: e18220.
19. Salazar JC, Duhnam-Ems S, La Vake C, Cruz AR, Moore MW, et al. (2009) Activation of human monocytes by live Borrelia burgdorferi generates TLR2-dependent and -independent responses which include induction of IFN-beta. PLoS Pathog 5: e1000444.
20. Petzke MM, Brooks A, Krupna MA, Mordue D, Schwartz I (2009) Recognition of Borrelia burgdorferi, the Lyme disease spirochete, by TLR7 and TLR9 induces a type I IFN response by human immune cells. J Immunol 183: 5279-5292.
21. Cervantes JL, Dunham-Ems SM, La Vake CJ, Petzke MM, Sahay B, et al. (2011) Phagosomal signaling by Borrelia burgdorferi in human monocytes involves Toll-like receptor (TLR) 2 and TLR8 cooperativity and TLR8-mediated induction of IFN-{beta}. Proc Natl Acad Sci U S A 108: 3683-3688.
22. Cervantes JL, La Vake CJ, Weinerman B, Luu S, O'Connell C, et al. (2013) Human TLR8 is activated upon recognition of Borrelia burgdorferi RNA in the phagosome of human monocytes. J Leukoc Biol 94: 1231-1241. jlb.0413206 [pii]; 10.1189/jlb.0413206 [doi].
23. Love AC, Schwartz I, Petzke MM (2014) Borrelia burgdorferi RNA induces type I and type III interferons via TLR7 and contributes to the production of NF-kappaB-dependent cytokines. Infect Immun. IAI.01617-14 [pii]; 10.1128/IAI.01617-14 [doi].
24. Hawley KL, Olson CM Jr, Iglesias-Pedraz JM, Navasa N, Cervantes JL, et al. (2012) CD14 cooperates with complement receptor 3 to mediate MyD88-independent phagocytosis of Borrelia burgdorferi. Proc Natl Acad Sci U S A 109: 1228-1232.
25. Auerbuch V, Brockstedt DG, Meyer-Morse N, O'Riordan M, Portnoy DA (2004) Mice lacking the type I interferon receptor are resistant to Listeria monocytogenes . J Exp Med 200: 527-533. (Pubitemid 39121909)
26. Salazar JC, Pope CD, Sellati TJ, Feder HM Jr, Kiely TG, et al. (2003) Coevolution of markers of innate and adaptive immunity in skin and peripheral blood of patients with erythema migrans. J Immunol 171: 2660-2670. (Pubitemid 37025580)
27. Mancuso G, Gambuzza M, Midiri A, Biondo C, Papasergi S, et al. (2009) Bacterial recognition by TLR7 in the lysosomes of conventional dendritic cells. Nat Immunol 10: 587-594.
28. Carrero JA, Calderon B, Unanue ER (2004) Type I interferon sensitizes lymphocytes to apoptosis and reduces resistance to Listeria infection. J Exp Med 200: 535-540. (Pubitemid 39121910)
29. Carrero JA, Unanue ER (2007) Impact of lymphocyte apoptosis on the innate immune stages of infection. Immunol Res 38: 333-341. (Pubitemid 47574917)
30. Kotenko SV, Gallagher G, Baurin VV, Lewis-Antes A, Shen M, et al. (2003) IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex. Nat Immunol 4: 69-77. (Pubitemid 36109115)
31. Sheppard P, Kindsvogel W, Xu W, Henderson K, Schlutsmeyer S, et al. (2003) IL-28, IL-29 and their class II cytokine receptor IL-28R. Nat Immunol 4: 63-68. (Pubitemid 36104710)
32. Coccia EM, Severa M, Giacomini E, Monneron D, Remoli ME, et al. (2004) Viral infection and Toll-like receptor agonists induce a differential expression of type I and lambda interferons in human plasmacytoid and monocyte-derived dendritic cells. Eur J Immunol 34: 796-805. (Pubitemid 39255927)
33. Wolk K, Witte K, Witte E, Proesch S, Schulze-Tanzil G, et al. (2008) Maturing dendritic cells are an important source of IL-29 and IL-20 that may cooperatively increase the innate immunity of keratinocytes. J Leukoc Biol 83: 1181-1193.
34. Pietila TE, Latvala S, Osterlund P, Julkunen I (2010) Inhibition of dynamin-dependent endocytosis interferes with type III IFN expression in bacteriainfected human monocyte-derived DCs. J Leukoc Biol 88: 665-674.
35. Lebreton A, Lakisic G, Job V, Fritsch L, Tham TN, et al. (2011) A bacterial protein targets the BAHD1 chromatin complex to stimulate type III interferon response. Science 331: 1319-1321.
36. Bierne H, Travier L, Mahlakoiv T, Tailleux L, Subtil A, et al. (2012) Activation of type III interferon genes by pathogenic bacteria in infected epithelial cells and mouse placenta. PLoS One 7: e39080. 10.1371/journal.pone. 0039080 [doi];PONE-D-12-04118 [pii].
37. Jewell NA, Cline T, Mertz SE, Smirnov SV, Flano E, et al. (2010) Lambda interferon is the predominant interferon induced by influenza A virus infection in vivo. J Virol 84: 11515-11522. JVI.01703-09 [pii];10.1128/JVI.01703-09 [doi].
38. Krupna MA, Wormser GP, Schwartz I, Petzke MM (2011) Borrelia burgdorferi pathogenic potential correlates with type I and type III IFN production by human immune cells. J Immunol.
39. Sadziene A, Wilske B, Ferdows MS, Barbour AG (1993) The cryptic ospC gene of Borrelia burgdorferi B31 is located on a circular plasmid. Infect Immun 61: 2192-2195. (Pubitemid 23145930)
40. Labandeira-Rey M, Skare JT (2001) Decreased infectivity in Borrelia burgdorferi strain B31 is associated with loss of linear plasmid 25 or 28-1. Infect Immun 69: 446-455. (Pubitemid 32038344)
41. Labandeira-Rey M, Seshu J, Skare JT (2003) The absence of linear plasmid 25 or 28-1 of Borrelia burgdorferi dramatically alters the kinetics of experimental infection via distinct mechanisms. Infect Immun 71: 4608-4613. (Pubitemid 36919927)
42. Grimm D, Tilly K, Bueschel DM, Fisher MA, Policastro PF, et al. (2005) Defining plasmids required by Borrelia burgdorferi for colonization of tick vector Ixodes scapularis (Acari: Ixodidae). J Med Entomol 42: 676-684. (Pubitemid 41040472)
43. Jewett MW, Lawrence K, Bestor AC, Tilly K, Grimm D, et al. (2007) The critical role of the linear plasmid lp36 in the infectious cycle of Borrelia burgdorferi. Mol Microbiol 64: 1358-1374. (Pubitemid 46849024)
44. Teetson W, Cartwright C, Dreiling BJ, Steinberg MH (1983) The leukocyte composition of peripheral blood buffy coat. Am J Clin Pathol 79: 500-501. (Pubitemid 13113748)
45. Ziegler-Heitbrock L, Ancuta P, Crowe S, Dalod M, Grau V, et al. (2010) Nomenclature of monocytes and dendritic cells in blood. Blood 116: e74-e80.
46. Siegal FP, Kadowaki N, Shodell M, Fitzgerald-Bocarsly PA, Shah K, et al. (1999) The nature of the principal type 1 interferon-producing cells in human blood. Science 284: 1835-1837.
47. Gregorio J, Meller S, Conrad C, Di NA, Homey B, et al. (2010) Plasmacytoid dendritic cells sense skin injury and promote wound healing through type I interferons. J Exp Med 207: 2921-2930.
48. Iyer R, Kalu O, Purser J, Norris S, Stevenson B, et al. (2003) Linear and circular plasmid content in Borrelia burgdorferi clinical isolates. Infect Immun 71: 3699-3706. (Pubitemid 36753689)
49. Strle K, Jones KL, Drouin EE, Li X, Steere AC (2011) Borrelia burgdorferi RST1 (OspC type A) genotype is associated with greater inflammation and more severe Lyme disease. Am J Pathol 178: 2726-2739.
50. Anguita J, Samanta S, Revilla B, Suk K, Das S, et al. (2000) Borrelia burgdorferi gene expression in vivo and spirochete pathogenicity. Infect Immun 68: 1222-1230. (Pubitemid 30108514)
51. Purser JE, Norris SJ (2000) Correlation between plasmid content and infectivity in Borrelia burgdorferi. Proc Natl Acad Sci U S A 97: 13865-13870.
52. Schwan TG, Burgdorfer W, Garon CF (1988) Changes in infectivity and plasmid profile of the Lyme disease spirochete, Borrelia burgdorferi, as a result of in vitro cultivation. Infect Immun 56: 1831-1836.
53. Xu Y, Kodner C, Coleman L, Johnson RC (1996) Correlation of plasmids with infectivity of Borrelia burgdorferi sensu stricto type strain B31. Infect Immun 64: 3870-3876. (Pubitemid 26298717)
54. He M, Boardman BK, Yan D, Yang XF (2007) Regulation of expression of the fibronectin-binding protein BBK32 in Borrelia burgdorferi. J Bacteriol 189: 8377-8380. (Pubitemid 350178953)
55. Li X, Liu X, Beck DS, Kantor FS, Fikrig E (2006) Borrelia burgdorferi lacking BBK32, a fibronectin-binding protein, retains full pathogenicity. Infect Immun 74: 3305-3313. (Pubitemid 43794518)
56. Seshu J, Esteve-Gassent MD, Labandeira-Rey M, Kim JH, Trzeciakowski JP, et al. (2006) Inactivation of the fibronectin-binding adhesin gene bbk32 significantly attenuates the infectivity potential of Borrelia burgdorferi. Mol Microbiol 59: 1591-1601.
57. Coleman AS, Rossmann E, Yang X, Song H, Lamichhane CM, et al. (2011) BBK07 Immunodominant Peptides as Serodiagnostic Markers of Lyme Disease. Clin Vaccine Immunol 18: 406-413.
58. Coleman AS, Pal U (2009) BBK07, a dominant in vivo antigen of Borrelia burgdorferi, is a potential marker for serodiagnosis of Lyme disease. Clin Vaccine Immunol 16: 1569-1575.
59. Pal U, Wang P, Bao F, Yang X, Samanta S, et al. (2008) Borrelia burgdorferi basic membrane proteins A and B participate in the genesis of Lyme arthritis. J Exp Med 205: 133-141. (Pubitemid 351185721)
60. Schutzer SE, Fraser-Liggett CM, Casjens SR, Qiu WG, Dunn JJ, et al. (2011) Whole-genome sequences of thirteen isolates of Borrelia burgdorferi. J Bacteriol 193: 1018-1020.
61. Barthold SW, Moody KD, Terwilliger GA, Duray PH, Jacoby RO, et al. (1988) Experimental Lyme arthritis in rats infected with Borrelia burgdorferi. J Infect Dis 157: 842-846. (Pubitemid 18093753)
62. Casjens SR, Mongodin EF, Qiu WG, Luft BJ, Schutzer SE, et al. (2012) Genome stability of Lyme disease spirochetes: comparative genomics of Borrelia burgdorferi plasmids. PLoS One 7: e33280.
63. Qiu WG, Schutzer SE, Bruno JF, Attie O, Xu Y, et al. (2004) Genetic exchange and plasmid transfers in Borrelia burgdorferi sensu stricto revealed by three-way genome comparisons and multilocus sequence typing. Proc Natl Acad Sci U S A 101: 14150-14155. (Pubitemid 39305045)
64. Bogdan C, Mattner J, Schleicher U (2004) The role of type I interferons in nonviral infections. Immunol Rev 202: 33-48. (Pubitemid 39576903)
65. Rothfuchs AG, Gigliotti D, Palmblad K, Andersson U, Wigzell H, et al. (2001) IFN-alpha beta-dependent, IFN-gamma secretion by bone marrow-derived macrophages controls an intracellular bacterial infection. J Immunol 167: 6453-6461. (Pubitemid 33081579)
66. de la Maza LM, Peterson EM, Goebel JM, Fennie CW, Czarniecki CW (1985) Interferon-induced inhibition of Chlamydia trachomatis: dissociation from antiviral and antiproliferative effects. Infect Immun 47: 719-722. (Pubitemid 15075866)
67. Kazar J, Gillmore JD, Gordon FB (1971) Effect of Interferon and Interferon Inducers on Infections with a Nonviral Intracellular Microorganism, Chlamydia trachomatis. Infect Immun 3: 825-832.
68. Hess CB, Niesel DW, Klimpel GR (1989) The induction of interferon production in fibroblasts by invasive bacteria: a comparison of Salmonella and Shigella species. Microb Pathog 7: 111-120. (Pubitemid 20007526)
69. Hess CB, Niesel DW, Cho YJ, Klimpel GR (1987) Bacterial invasion of fibroblasts induces interferon production. J Immunol 138: 3949-3953. (Pubitemid 17078278)
70. Niesel DW, Hess CB, Cho YJ, Klimpel KD, Klimpel GR (1986) Natural and recombinant interferons inhibit epithelial cell invasion by Shigella spp. Infect Immun 52: 828-833. (Pubitemid 16119850)
71. Bukholm G, Berdal BP, Haug C, Degre M (1984) Mouse fibroblast interferon modifies Salmonella typhimurium infection in infant mice. Infect Immun 45: 62-66. (Pubitemid 14078918)
72. Lindahl G, Stalhammar-Carlemalm M, Areschoug T (2005) Surface proteins of Streptococcus agalactiae and related proteins in other bacterial pathogens. Clin Microbiol Rev 18: 102-127. (Pubitemid 40170663)
73. Mancuso G, Midiri A, Biondo C, Beninati C, Zummo S, et al. (2007) Type I IFN signaling is crucial for host resistance against different species of pathogenic bacteria. J Immunol 178: 3126-3133. (Pubitemid 46333194)
74. O'connell RM, Saha SK, Vaidya SA, Bruhn KW, Miranda GA, et al. (2004) Type I interferon production enhances susceptibility to Listeria monocytogenes infection. J Exp Med 200: 437-445.
75. Bouchonnet F, Boechat N, Bonay M, Hance AJ (2002) Alpha/beta interferon impairs the ability of human macrophages to control growth of Mycobacterium bovis BCG. Infect Immun 70: 3020-3025. (Pubitemid 34564162)
76. Manca C, Tsenova L, Bergtold A, Freeman S, Tovey M, et al. (2001) Virulence of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-alpha/beta. Proc Natl Acad Sci U S A 98: 5752-5757. (Pubitemid 32435714)
77. Loughman JA, Hunstad DA (2012) Induction of indoleamine 2,3-dioxygenase by uropathogenic bacteria attenuates innate responses to epithelial infection. J Infect Dis.
78. Crandall H, Dunn DM, Ma Y, Wooten RM, Zachary JF, et al. (2006) Gene expression profiling reveals unique pathways associated with differential severity of lyme arthritis. J Immunol 177: 7930-7942. 177/11/7930 [pii].
79. Miller JC, Ma Y, Bian J, Sheehan KC, Zachary JF, et al. (2008) A critical role for type I IFN in arthritis development following Borrelia burgdorferi infection of mice. J Immunol 181: 8492-8503. 181/12/8492 [pii].
80. Numasaki M, Tagawa M, Iwata F, Suzuki T, Nakamura A, et al. (2007) IL-28 elicits antitumor responses against murine fibrosarcoma. J Immunol 178: 5086-5098. (Pubitemid 46595292)
81. Li Q, Kawamura K, Ma G, Iwata F, Numasaki M, et al. (2010) Interferon-lambda induces G1 phase arrest or apoptosis in oesophageal carcinoma cells and produces anti-tumour effects in combination with anti-cancer agents. Eur J Cancer 46: 180-190.
82. Li W, Lewis-Antes A, Huang J, Balan M, Kotenko SV (2008) Regulation of apoptosis by type III interferons. Cell Prolif 41: 960-979.
83. Baban B, Chandler PR, Sharma MD, Pihkala J, Koni PA, et al. (2009) IDO activates regulatory T cells and blocks their conversion into Th17-like T cells. J Immunol 183: 2475-2483.
84. Mellor A (2005) Indoleamine 2,3 dioxygenase and regulation of T cell immunity. Biochem Biophys Res Commun 338: 20-24.
85. Mellor AL, Munn DH (2004) IDO expression by dendritic cells: tolerance and tryptophan catabolism. Nat Rev Immunol 4: 762-774. (Pubitemid 39336293)
86. Le BH, Gougeon ML, Mathian A, Lebon P, Dupont JM, et al. (2011) IFN-alpha and CD46 stimulation are associated with active lupus and skew natural T regulatory cell differentiation to type 1 regulatory T (Tr1) cells. Proc Natl Acad Sci U S A 108: 18995-19000.
87. Li W, Katz BP, Spinola SM (2011) Haemophilus ducreyi lipooligosaccharides induce expression of the immunosuppressive enzyme indoleamine 2,3- dioxygenase via type I interferons and tumor necrosis factor alpha in human dendritic cells. Infect Immun 79: 3338-3347.
88. Makala LH, Baban B, Lemos H, El-Awady AR, Chandler PR, et al. (2011) Leishmania major attenuates host immunity by stimulating local indoleamine 2,3-dioxygenase expression. J Infect Dis 203: 715-725.
89. von Bubnoff D, Scheler M, Wilms H, Wenzel J, von Bubnoff N, et al. (2011) Indoleamine 2,3-dioxygenase-expressing myeloid dendritic cells and macrophages in infectious and noninfectious cutaneous granulomas. J Am Acad Dermatol 65: 819-832.
90. Scheler M, Wenzel J, Tuting T, Takikawa O, Bieber T, et al. (2007) Indoleamine 2,3-dioxygenase (IDO): the antagonist of type I interferon-driven skin inflammation? Am J Pathol 171: 1936-1943.
91. Bourreau E, Ronet C, Darcissac E, Lise MC, Sainte MD, et al. (2009) Intralesional regulatory T-cell suppressive function during human acute and chronic cutaneous leishmaniasis due to Leishmania guyanensis. Infect Immun 77: 1465-1474.
92. Babolin C, Amedei A, Ozolins D, Zilevica A, D'Elios MM, et al. (2011) TpF1 from Treponema pallidum activates inflammasome and promotes the development of regulatory T cells. J Immunol 187: 1377-1384.
93. Filgueira L, Nestle FO, Rittig M, Joller HI, Groscurth P (1996) Human dendritic cells phagocytose and process Borrelia burgdorferi. J Immunol 157: 2998-3005. (Pubitemid 126450058)
94. Hovius JW, de Jong MA, den Dunnen J, Litjens M, Fikrig E, et al. (2008) Salp15 binding to DC-SIGN inhibits cytokine expression by impairing both nucleosome remodeling and mRNA stabilization. PLoS Pathog 4: e31.
95. Schwartz I, Wormser GP, Schwartz JJ, Cooper D, Weissensee P, et al. (1992) Diagnosis of early Lyme disease by polymerase chain reaction amplification and culture of skin biopsies from erythema migrans lesions. J Clin Microbiol 30: 3082-3088.
96. Wang G, Iyer R, Bittker S, Cooper D, Small J, et al. (2004) Variations in Barbour-Stoenner-Kelly culture medium modulate infectivity and pathogenicity of Borrelia burgdorferi clinical isolates. Infect Immun 72: 6702-6706. (Pubitemid 39425457)
97. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408. (Pubitemid 34164012)
98. Eggers CH, Caimano MJ, Clawson ML, Miller WG, Samuels DS, et al. (2002) Identification of loci critical for replication and compatibility of a Borrelia burgdorferi cp32 plasmid and use of a cp32-based shuttle vector for the expression of fluorescent reporters in the lyme disease spirochaete. Mol Microbiol 43: 281-295. (Pubitemid 34146722)
99. Samuels DS (1995) Electrotransformation of the spirochete Borrelia burgdorferi. Methods Mol Biol 47: 253-259.
100. Kenedy MR, Vuppala SR, Siegel C, Kraiczy P, Akins DR (2009) CspA-mediated binding of human factor H inhibits complement deposition and confers serum resistance in Borrelia burgdorferi. Infect Immun 77: 2773-2782.
101. Elias AF, Stewart PE, Grimm D, Caimano MJ, Eggers CH, et al. (2002) Clonal polymorphism of Borrelia burgdorferi strain B31 MI: implications for mutagenesis in an infectious strain background. Infect Immun 70: 2139-2150. (Pubitemid 34242216)